"DHL" plans to invest half billion euros to expand in Africa and the Middle East

The DHL Group (DHL), giant in logistics services, plans to invest approximately 500 million euros ($ 575 million) in the health care services in Africa and the Middle East during the next five years, and utilize the growing Chinese momentum in these two regions. Ante Nodi, head of the healthcare sector in the Europe, the Middle East and the African region, said during an interview that the German company focuses on Africa as an important growth area, while targeting to be delivered during a very specific and rapid period, including vaccines, stem cells and applications associated with deep freezing or storing materials). “We note that the United States intervened and lowered the costs, but we also see other countries that start to lead the scene and clog these gaps,” Nod said. ‘I traveled to China and met a number of investors who intended to pump investments on the African continent. The size of the Chinese investment in the region is already large. ‘ An increasing demand for medicine in Africa The African continent is the fastest growth of the population, and the demand for drug products is increasing, and the revenue of this sector is expected to reach $ 2030, according to estimates of “Grand View Research” (Grand Vio Research). Nodi said the “DHL” direction to Africa and the Middle East is part of a global investment plan in the healthcare sector worth 2 billion euros, which is expected to get about 25% of them. The “DHL” centers in the Middle East are most of the “DHL” operations in Africa and the Middle East, including storage, packaging and the management of supply chains in South Africa, Egypt, Kenya, Dubai and Saudi Arabia. NOD said that the assurance that medicine and medical devices are accurately followed from the production phase and until the final destination is one of the basic focus areas. She explained that it necessitated the presence of specialized warehouses “that enables the handling of highly freezing charges and provides a coding system and pharmaceutical order.” And she said, “If the doctor prescribes a medicine for a patient next to his bed, he must fully trust the transport network that brought the medicine to him.” New health challenges and sophisticated solutions have made it clear that the treatment of endemic diseases is long known, as malaria remains a primary priority, but new challenges have begun to appear in Africa. Obtaining a technological insulin from China also receives increasing attention from governments, due to the ease of use and long -acting composition that reduces the need to repeat the injection. NOD said China and DHL recently worked together to establish a specialized facility for the manufacture of medical devices in Kenya and export its equipment to both the Middle East and Europe.